Tirzepatide TR15 is a synthetic modified peptide research compound used to study metabolic regulation mechanisms, receptor effects, and peptide pharmacology via the GLP-1 and GIP dual receptor signaling pathways.
Tirzepatide TR15 is a synthetic esterified peptide compound consisting of 39 amino acids, belonging to the GLP-1/GIP dual receptor agonist class. This molecule\'s research value is enhanced through structural optimization and fatty acid modification, enabling the exploration of the incretin receptor signaling pathway, cellular metabolic regulation mechanisms, and the structure-function relationship of multi-target peptide molecules. The product is supplied as a white to off-white lyophilized powder, and its quality is assessed by HPLC purity detection and LC-MS identification.
Tirzepatide TR15 is primarily used in metabolic biology, molecular pharmacology, and peptide engineering research, including studies of the GLP-1R/GIPR dual receptor signaling pathway, receptor binding mechanism analysis, cell signal transduction, glucose metabolism-related mechanisms, energy balance regulation, and the development of novel metabolic regulatory peptides. Researchers can utilize this compound to explore the synergistic effects of dual receptors and the regulatory mechanisms within complex metabolic networks.
Freeze-dried powder state:
Recommended:
Long-term storage:
-20℃
Requirements:
✅ Protect from light
✅ Dry
✅ Store in an airtight container
Avoid:
High temperatures
Repeated freeze-thaw cycles
Prolonged exposure to air
Retatrutide (RT10) is a synthetic peptide research compound designed as a triple...
Retatrutide (RT20) is a novel synthetic modified peptide, with the research code...
Retatrutide RT30 is a 30mg research-grade peptide product of Retatrutide (LY3437...
Contact our team for volume discounts and custom peptide services
Weitai Bio is a national high-tech enterprise specializing in the research, development, production, and sales of peptide drugs. It is also a leading global supplier of high-quality peptides, consistently focusing on peptide drugs and small nucleic acid fields.